Sort by
Refine Your Search
-
successful candidate, you will be: Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA
-
issues and/or risks to study team and clinical trials leadership. Ensure quality deliverables, including identifying quality risks, and developing corrective action plans to prevent and/or correct
-
. The ideal candidate will have experience in developing LC-MS-based methods, troubleshooting instrumentation, processing complex data, and creating SOPs for metabolite and lipid identification. As a successful
-
candidate, you will be: Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA methylation
-
that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and
-
discovery approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer
-
Epigenetics, Epigenetics Regulation, Cancer Metabolism, Immunology, Drug Discovery, Development, and Structural Biology, with an emphasis on RNA epigenetics/epitranscriptomics (RNA modifications) and RNA-based
-
this dynamic role, you’ll collaborate with leading researchers and clinicians to design and lead cutting-edge exercise programs, conduct physiological testing, and educate participants. You'll play a key role in
-
of laboratory work area and furnishings/equipment · Receive, distribute and maintain supply inventories in laboratories as needed · Prepare simple stains, solutions, culture media, and process
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies